文献速递胃肠外科

机器人与腹腔镜胃癌根治术倾向性评分匹配分析

Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis.
PubMed 文献 · Surg Endosc · 2022-02-28

该单中心倾向性评分匹配研究比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)治疗胃癌的短期和长期结局。匹配后各210对患者,RG组手术时间更短(201 min vs 231 min,p=0.0051)、出血量更少(13 mL vs 42 mL,p<0.0001)、术后并发症发生率更低(1.0% vs 4.8%,p=0.0066)、术后住院时间更短(p=0.0002),术后第1天和第3天引流液淀粉酶水平显著低于LG组(p<0.0001)。结论认为RG安全可行,但需多中心前瞻性随机对照试验进一步验证。

要点

  • RG组手术时间显著短于LG组(201 min vs 231 min,p=0.0051)。
  • RG组出血量显著少于LG组(13 mL vs 42 mL,p<0.0001)。
  • RG组术后并发症发生率显著低于LG组(1.0% vs 4.8%,p=0.0066)。

核心结论

  • RG是安全可行的胃癌治疗方式,手术时间更短、出血量更少、术后并发症发生率低于LG。
  • 机器人应用于微创胃癌手术可能为传统手术提供替代选择。
  • 需多中心前瞻性随机对照试验比较RG与常规LG以确立微创胃癌手术的可行性和疗效。

研究设计与样本

  • 排除残胃癌及同期因合并恶性肿瘤手术的患者。
  • 共纳入1189例患者(LG 979例,RG 210例),经1:1倾向性评分匹配后各选210对。

主要发现

  • 匹配后LG组远端胃切除138例、全胃或近端胃切除72例;RG组远端胃切除143例、全胃或近端胃切除67例。
  • RG组手术时间显著短于LG组(201 min vs 231 min,p=0.0051)。
  • RG组出血量显著少于LG组(13 mL vs 42 mL,p<0.0001)。
  • RG组术后并发症发生率显著低于LG组(1.0% vs 4.8%,p=0.0066)。
  • RG组术后住院时间显著短于LG组(p=0.0002);术后第1天和第3天引流液淀粉酶水平显著低于LG组(p<0.0001)。

临床怎么用

  • RG可作为胃癌微创手术的一种安全可行选择,但需多中心前瞻性随机对照试验进一步验证。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The benefits of robotic gastrectomy (RG) over laparoscopic gastrectomy (LG) remain controversial. This single-center, propensity score-matched study aimed to compare the outcomes of RG with those of LG for treating gastric cancer. METHODS: We searched the prospective gastric cancer database of our institute for patients with gastric cancer who underwent RG or LG between January 2014 and December 2019, excluding patients with remnant stomach cancer and those who underwent concurrent surgery for comorbid malignancies. One-to-one propensity score matching was performed to reduce bias from confounding patient-related variables, and short- and long-term outcomes were compared between the groups. RESULTS: We identified 1189 patients who underwent LG (n = 979) or RG (n = 210). After propensity score matching, we selected 210 pairs of patients who underwent LG (distal gastrectomy, 138; total or proximal gastrectomy, 72) or RG (distal gastrectomy, 143; total or proximal gastrectomy, 67). RG was associated with a significantly shorter operative time (RG = 201 min vs. LG = 231 min, p = 0.0051), less blood loss (RG = 13 mL vs. LG = 42 mL, p < 0.0001), lower postoperative morbidity (RG = 1.0% vs. LG = 4.8%, p = 0.0066), and a shorter postoperative hospital stay (p = 0.0002) than LG. Drain amylase levels on postoperative Days 1 and 3 in the RG group were significantly lower than those in the LG group (p < 0.0001). CONCLUSIONS: RG is a safe and feasible treatment for gastric cancer, with a shorter operative time, less blood loss, and lower postoperative morbidity than LG. The application of robotics in minimally invasive gastric cancer surgery may offer an alternative to conventional surgery. Multicenter, prospective, randomized controlled trials comparing RG with conventional LG are needed to establish the feasibility and efficacy of minimally invasive gastric cancer surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Omori T, Yamamoto K, Hara H, et al. Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis. Surg Endosc. 2022. PMID: 35229214. doi:10.1007/s00464-022-09125-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。